A Patients' Perspective Towards the Injection Devices for Humira� and Imraldi� in a Nationwide Switching Program

Objective Due to a tender process in Iceland, all patients on Humira® were switched nationwide to its biosimilar Imraldi® in March 2019. The study aimed to explore the patient's perspective of the Humira® and Imraldi® injection devices. Methods A standard telephone interview was carried out amo...

Full description

Bibliographic Details
Published in:Frontiers in Medicine
Main Authors: Karlsdottir, Kristin, Gunnarsdottir, Anna I., Grondal, Gerdur, Love, Thorvardur J., Stefansdottir, Elinborg, Davidsdottir, Loa G., Thorleifsdottir, Ragna H., Gudbjornsson, Bjorn
Format: Article in Journal/Newspaper
Language:unknown
Published: Frontiers Media SA 2022
Subjects:
General Medicine
The Needle
Iceland
Online Access:http://dx.doi.org/10.3389/fmed.2022.799494
https://www.frontiersin.org/articles/10.3389/fmed.2022.799494/full

Similar Items